Viewing Study NCT01296256


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-04-19 @ 11:09 PM
Study NCT ID: NCT01296256
Status: COMPLETED
Last Update Posted: 2016-02-17
First Post: 2011-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).
Sponsor:
Organization: